Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Linnebjerg

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
JAMA|March 27, 2024
Lepodisiran for Elevated Lipoprotein(a)-ReplySteven E Nissen, Helle Linnebjerg, Stephen J Nicholls
Clinical Pharmacokinetics|May 27, 2021
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog<sup>®</sup> Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic DataJennifer Leohr, Mary Anne Dellva, Kallin Carter, et al.
Clinical Therapeutics|May 16, 2022
Evaluation of the Pharmacokinetic Profile of Ultra Rapid Lispro Administered Subcutaneously at Different Injection SitesJennifer K Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2020
Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy SubjectsHelle Linnebjerg, Elizabeth Smith LaBell, Mary Anne Dellva, et al.
BMC Clinical Pharmacology|March 21, 2012
Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trialPrajakti A Kothare, Mary E Seger, Justin Northrup, et al.
British Journal of Clinical Pharmacology|April 12, 2007
Effect of renal impairment on the pharmacokinetics of exenatideHelle Linnebjerg, Prajakti A Kothare, Soomin Park, et al.
Regulatory Peptides|September 11, 2012
Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjectsJutta Keller, Michael E Trautmann, Harry Haber, et al.
Endocrine Journal|August 27, 2009
Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetesKazuya Iwamoto, Risa Nasu, Ayuko Yamamura, et al.
Journal of Clinical Pharmacology|September 22, 2006
Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian menDanny Soon, Prajakti A Kothare, Helle Linnebjerg, et al.
Clinical Pharmacology in Drug Development|May 11, 2016
Pharmacokinetics of the Long-Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal FunctionHelle Linnebjerg, Siak Leng Choi, Eric Chen Quin Lam, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
JAMA|March 27, 2024
Lepodisiran for Elevated Lipoprotein(a)-ReplySteven E Nissen, Helle Linnebjerg, Stephen J Nicholls
Clinical Pharmacokinetics|May 27, 2021
Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog<sup>®</sup> Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic DataJennifer Leohr, Mary Anne Dellva, Kallin Carter, et al.
Clinical Therapeutics|May 16, 2022
Evaluation of the Pharmacokinetic Profile of Ultra Rapid Lispro Administered Subcutaneously at Different Injection SitesJennifer K Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2020
Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy SubjectsHelle Linnebjerg, Elizabeth Smith LaBell, Mary Anne Dellva, et al.
BMC Clinical Pharmacology|March 21, 2012
Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trialPrajakti A Kothare, Mary E Seger, Justin Northrup, et al.
British Journal of Clinical Pharmacology|April 12, 2007
Effect of renal impairment on the pharmacokinetics of exenatideHelle Linnebjerg, Prajakti A Kothare, Soomin Park, et al.
Regulatory Peptides|September 11, 2012
Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjectsJutta Keller, Michael E Trautmann, Harry Haber, et al.
Endocrine Journal|August 27, 2009
Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetesKazuya Iwamoto, Risa Nasu, Ayuko Yamamura, et al.
Journal of Clinical Pharmacology|September 22, 2006
Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian menDanny Soon, Prajakti A Kothare, Helle Linnebjerg, et al.
Clinical Pharmacology in Drug Development|May 11, 2016
Pharmacokinetics of the Long-Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal FunctionHelle Linnebjerg, Siak Leng Choi, Eric Chen Quin Lam, et al.
Pageof 4